Advanced methods, such as high-throughput sequencing, single-cell analysis, and in vivo and in vitro models, are being employed to elucidate the molecular mechanisms of the PD1/PD-L1 pathway in tumor immune evasion in ccRCC. The gene discussed is CD274; the disease is neoplasm.